Physician profile
Michael W Schaeffer
NPI 1144257163
$10,280.80
in general payments reported to CMS, 2019-2025
26 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,799 · 2020: $984 · 2021: $802 · 2022: $2,498 · 2023: $2,509 · 2024: $357 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,766 · Food and Beverage: $1,415 · Education: $16.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,765.92 |
| Food and Beverage | $1,415.46 |
| Education | $16.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $6,292.78 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $986.79 | 2019-2025 | Avvigo Guidance System |
| Janssen Pharmaceuticals, INC | $747.64 | 2019-2023 | Xarelto |
| Abbott Laboratories | $303.56 | 2019-2025 | Navitor, Amplatzer Amulet, Mitraclip |
| Novartis Pharmaceuticals Corporation | $281.39 | 2019-2024 | |
| Novo Nordisk INC | $192.74 | 2019-2024 | Rybelsus, Ozempic |
| Shockwave Medical, INC | $185.98 | 2022 | |
| Inari Medical, INC. | $171.04 | 2020 | |
| Amgen INC. | $168.00 | 2020-2023 | Repatha |
| Pfizer INC. | $166.15 | 2019-2023 | |
| Medtronic, INC. | $158.84 | 2021-2022 | |
| Abiomed | $154.76 | 2024 | |
| Sanofi-Aventis U.S. LLC | $154.15 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $46.66 | 2021-2022 | |
| Angiodynamics, INC. | $40.32 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $38.99 | 2023 | Brilinta |
| E.R. Squibb & Sons, L.L.C. | $38.01 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $34.10 | 2023 | Inpefa |
| Alnylam Pharmaceuticals INC. | $23.08 | 2022 | |
| Medtronic Vascular, INC. | $18.54 | 2019 | |
| Imperative Care, INC | $15.56 | 2023 | Symphony Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.17 | 2020 | |
| Scpharmaceuticals INC. | $13.72 | 2023 | |
| Philips North America LLC | $12.13 | 2019 | |
| Lundbeck LLC | $11.36 | 2019 | |
| Surmodics, INC. | $9.34 | 2024 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.